Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in ...

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Ozempic and other GLP-1 drugs are now being recommended by a top health organization in a major shift on how a chronic ...

As people’s bodies change because of GLP-1s, so does their spending across industries including fashion, restaurants, gyms ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Doctors have warned of a surge in teenagers being referred to medics after using weight-loss drugs they purchased online, ...

Ozempic and access to generics: a five-year exclusivity clause could delay the arrival of affordable versions in Morocco.

Last year, the U.S. Food and Drug Administration banned the sale of compounded weight loss drugs, which are often much ...